Inefficacy of chromogranin a assays as neuroendocrine tumor diagnostic tools compared to the NETest.

4612Background: Chromogranin A (CgA) remains a commonly used diagnostic and monitoring tool for neuroendocrine tumor disease despite NCCN guidelines identifying it as a category 3 (major concerns a...